- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignant Pleural Effusion in United Kingdom
Total 3105 results
-
Smiths Medical, ASD, Inc.CompletedHome Healthcare Organizations Utilizing Ambulatory Infusion Pumps | Patients Requiring Infusion With an Ambulatory Infusion PumpUnited States
-
National Cancer Institute (NCI)TerminatedMesotheliomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.Terminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; University of ChicagoCompletedMesotheliomaUnited States
-
Taxolog Inc.UnknownMesotheliomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Nodular Malignant Melanoma | Solar Radiation-related Skin Melanoma | Superficial Spreading Malignant MelanomaUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingGlioma | Melanoma | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Neoplasms by Site | Cancer | Brain Neoplasms | Solid Tumor | Malignant Neoplasm | Malignancy | Haematological MalignancyUnited Kingdom
-
Novartis PharmaceuticalsRecruitingMesotheliomaAustralia, Switzerland, Italy, Spain, Canada, Germany, Japan, United Kingdom, Netherlands, United States, France
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbRecruitingMesotheliomaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Recruiting
-
Baylor College of MedicineCompletedMesotheliomaUnited States
-
National Cancer Institute (NCI)CompletedMesotheliomaUnited States
-
Mayo ClinicCSA Medical, Inc.Terminated
-
National Cancer Institute (NCI)Completed
-
University of Texas Southwestern Medical CenterUniversity of Chicago; Columbia University; Duke UniversityCompletedMesotheliomaUnited States
-
ProgenaBiomeCompletedMesotheliomaUnited States
-
University of Alabama at BirminghamNovartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Baylor College of MedicineDuke Cancer InstituteNot yet recruitingMesotheliomaUnited States
-
Sagimet Biosciences Inc.CompletedSolid Malignant TumorUnited Kingdom, United States
-
Jonsson Comprehensive Cancer CenterWithdrawnMesotheliomaUnited States
-
University of Southern CaliforniaSponsor Name PendingWithdrawn
-
University of Milano BicoccaAzienda Ospedaliera San Gerardo di MonzaCompletedCOVID-19 | Pneumothorax | Hemothorax | Abscess | Surgical Complication | Empyema, Pleural | ThoracicItaly, United States, Brazil, India, United Kingdom
-
Arkadiusz Z. Dudek, MDBristol-Myers Squibb; Eli Lilly and Company; HealthPartners Institute Regions...TerminatedMesothelioma, MalignantUnited States
-
Immodulon Therapeutics LtdTerminatedMalignant MelanomaUnited Kingdom
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLung Cancer | MesotheliomaUnited States
-
M.D. Anderson Cancer CenterCompletedLung Cancer | MesotheliomaUnited States
-
King's College Hospital NHS TrustKing's College LondonNot yet recruiting
-
University of Missouri-ColumbiaWithdrawnFood Hypersensitivity | Otitis Media With EffusionUnited States
-
BayerImmunoGen and MorphoSysCompletedMesotheliomaBelgium, France, United States, Canada, Spain, Turkey, United Kingdom, Australia, Finland, Italy, Poland, Korea, Republic of, Netherlands, Russian Federation
-
Wake Forest UniversityJohns Hopkins University; Memorial Sloan Kettering Cancer Center; Mayo Clinic; University... and other collaboratorsCompleted
-
University of Illinois at ChicagoMillennium Pharmaceuticals, Inc.CompletedMelanoma | Head and Neck Neoplasms | Malignant Neoplasm of Breast | Malignant Neoplasm of Thorax | CNS Malignancy | Malignant Neoplasm of Gastrointestinal Tract | Genitourinary Neoplasms Malignancy and Gender UnspecifiedUnited States
-
Universitaire Ziekenhuizen KU LeuvenUniversity of Pittsburgh; Sheba Medical Center; Mount Sinai Hospital, Canada; Leiden... and other collaboratorsUnknownTwin Reversal Arterial Perfusion SyndromeSpain, Germany, Israel, Belgium, Netherlands, Canada, United States, Austria, France, Italy, United Kingdom
-
University of ChicagoCompletedMesothelioma | Peritoneal MesotheliomaUnited States
-
University of ChicagoActive, not recruitingMesothelioma | Peritoneal MesotheliomaUnited States
-
CSA Medical, Inc.TerminatedLung Cancer | MesotheliomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Peritoneal Malignant Mesothelioma | Recurrent Pleural Malignant Mesothelioma | Vaginal Squamous Cell Carcinoma, Not Otherwise Specified | Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor | Recurrent Merkel Cell Carcinoma | Recurrent Nasopharynx Carcinoma | Appendix Adenocarcinoma and other conditionsUnited States
-
Boehringer IngelheimTerminatedMesotheliomaUnited States, Spain, Canada, United Kingdom, Belgium, Czechia, Sweden, Australia, Germany, Italy, Japan, Russian Federation, Israel, Poland, France, Netherlands, Austria, Mexico, Portugal, Egypt, Argentina, Croatia, Chile, Denmark, Norway and more
-
CSA Medical, Inc.TerminatedCancer | Pleural NeoplasmsUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer CenterTerminatedMesotheliomaUnited States
-
University of OxfordTerminated
-
Royal Marsden NHS Foundation TrustUnknown
-
SanofiCompletedNeoplasm MalignantNetherlands, Belgium, Spain, Italy, United Kingdom
-
Eli Lilly and CompanyApproved for marketingALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.MesotheliomaUnited States, Brazil, Egypt, Saudi Arabia
-
Memorial Sloan Kettering Cancer CenterCompletedMesotheliomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingPrimary Effusion Lymphoma | B-Cell NeoplasmUnited States
-
University of Southern CaliforniaTerminatedNon-Hodgkin's Lymphoma | Burkitt Lymphoma | Primary Effusion LymphomasUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Cutaneous Melanoma | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System Neoplasm | Recurrent Lip and Oral Cavity Carcinoma | Recurrent Malignant Endocrine... and other conditionsUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedMesotheliomaBrazil, United States, China, Italy, Australia, Belgium, Chile, Colombia, France, Germany, Greece, Japan, Mexico, Netherlands, Poland, Romania, Russian Federation, South Africa, Switzerland, Turkey, United Kingdom